Status
Conditions
Treatments
About
In the field of urology, sacral neuromodulation (SNM) is a well-accepted, second-line, minimally invasive treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with non-obstructive urinary retention (NOUR).
Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
100 participants in 2 patient groups
Loading...
Central trial contact
Stefan De Wachter, MD PhD FEBU
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal